LENZ Therapeutics, Inc. Common Stock

LENZ XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

170M

Short interest (Jun 30)

33.3%

Net Short (Jul 27 ): 0.0%

Borrow Fee

0.80%

↑ 3.3%

Available Shares

500K

↑ 63.6%

Price Chart

Company Overview

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001815776

Asset Type: CS

Market Data

Market Cap: $171,822,079

Employees: 152

Status: Active

Short Interest

Current Borrow Fee 0.80%

Range: 0.80% - 0.81%

Available Shares 500K

Range: 400K - 500K

Recent Changes

Fee Change: ↓ 4.5%

Available Change: ↑ 5.6%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime